Wolfgang Pusch, President of the BMID Group at Bruker Corp (NASDAQ:BRKR), filed a Form 4 on August 18, 2026, reporting equity awards granted on August 15, 2026, and an open-market sale of common stock on August 17, 2026.

Key Highlights

  • RSU grant: Pusch acquired 3,120 restricted stock units on August 15, 2026, at $0 cost, vesting in equal installments on the first through fourth anniversaries of the grant date.
  • Stock option grant: Pusch received options to purchase 2,529 shares of common stock at an exercise price of $57.7, also granted August 15, 2026, vesting on the same four-year schedule, exercisable beginning August 15, 2027, and expiring August 15, 2036.
  • Open-market sale: Pusch disposed of 3,473 shares of common stock on August 17, 2026, at a price of $56.9 per share.
  • Remaining direct ownership: Following all reported transactions, Pusch directly held 9,801 shares of common stock and 2,529 derivative securities (stock options).
  • Filing form: All reported transactions reflect direct ownership; no indirect beneficial ownership was reported.

Bruker BMID Group President Reports August 2026 Equity Transactions

According to the Form 4 filed with the SEC on August 18, 2026, Wolfgang Pusch, who serves as President of the BMID Group at Bruker Corp, reported two equity awards and one disposition of common stock. On August 15, 2026, the filing discloses that Pusch acquired 3,120 restricted stock units classified as transaction code "A" (acquired) at a price of $0. The filing states these RSUs vest in equal installments on the first, second, third, and fourth anniversaries of the August 15, 2026 grant date.

On the same date, Pusch also received a stock option grant covering 2,529 shares of Bruker common stock, with an exercise price of $57.7 per share and a $0 price for the derivative security itself. Per the filing, these options vest on the same four-year anniversary schedule, become exercisable beginning August 15, 2027, and expire on August 15, 2036. The filing records 2,529 derivative securities beneficially owned following this transaction, held directly.

On August 17, 2026, Pusch disposed of 3,473 shares of common stock in an open-market sale coded "S" at $56.9 per share. Prior to the sale, the RSU acquisition had brought Pusch's directly held common stock to 13,274 shares; following the sale, the filing reports 9,801 shares of common stock held directly. The Form 4 was signed by Michael Simone as Attorney-in-Fact and filed on August 18, 2026.

What Was Disclosed

The filing reports two equity grants, including 3,120 RSUs and options for 2,529 shares, both dated August 15, 2026, and a sale of 3,473 common shares at $56.9 on August 17, 2026, leaving Pusch with 9,801 shares directly held.